Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 7:32 PM
Ignite Modification Date:
2025-12-24 @ 7:32 PM
NCT ID:
NCT06942403
Brief Summary:
The aim of this study is to assess the dermatological tolerance of the investigational product "Crème visage Product code: RV4983A / Formula code: LA3365" after 95 days for subjects post peeling and LASER and 176 days for subjects post injections of once daily use at the evening on the half face, under normal conditions of use, on 66 subjects.
This study will be conducted as a national, monocentric, open trial.
Planning of the visits:
* Visit 1: Inclusion (Day 1) - The subjects undergo their procedure (peeling, LASER or injections).
* Home application of the associated product 1 period: Day 1 to Day 7
* Visit 2: intermediate visit (Day 8) subjects received investigational product and associated product 2;
* Visit 3, 4, and 5: Intermediate visit (Day 37, Day 66 and Day 95\*),
\*the final visit for the subjects post peeling and LASER
* Visit 6\*\*: End of study (Day 176), \*\* for subjects post injections
Study:
NCT06942403
Study Brief:
Protocol Section:
NCT06942403